HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Johanna Auriau Selected Research
Johanna Auriau Research Topics
Disease
3
Neoplasms (Cancer)
09/2022 - 01/2014
2
Inflammation (Inflammations)
01/2021 - 01/2019
1
Adenocarcinoma
09/2022
1
Pancreatic Neoplasms (Pancreatic Cancer)
09/2022
1
Noonan Syndrome (Female Pseudo-Turner Syndrome)
01/2021
1
Obesity
01/2021
1
Insulin Resistance
01/2021
1
Chronic Renal Insufficiency
01/2019
1
Hypertrophy
01/2019
1
Sarcopenia
01/2019
1
Breast Neoplasms (Breast Cancer)
01/2014
Drug/Important Bio-Agent (IBA)
2
Apelin
IBA
09/2022 - 01/2019
2
Glucose (Dextrose)
FDA Link
Generic
09/2022 - 01/2021
1
Proteins (Proteins, Gene)
FDA Link
09/2022
1
Cyclin D1
IBA
09/2022
1
Catenins
IBA
09/2022
1
Apelin Receptors
IBA
09/2022
1
Tyrosine (L-Tyrosine)
FDA Link
01/2021
1
Non-Receptor Type 11 Protein Tyrosine Phosphatase
IBA
01/2021
1
Lipids
IBA
01/2021
1
Hypoglycemic Agents (Hypoglycemics)
IBA
01/2021
1
Collagen
IBA
01/2019
1
Peptides (Polypeptides)
IBA
01/2019
1
ErbB Receptors (EGF Receptor)
IBA
01/2014
1
Cetuximab (Erbitux)
FDA Link
01/2014
1
Tyrosine Kinase Inhibitors
IBA
01/2014
1
Monoclonal Antibodies
IBA
01/2014
1
Epidermal Growth Factor (EGF)
IBA
01/2014
1
Insulin (Novolin)
FDA Link
01/2014
1
Phosphates (Orthophosphate)
IBA
01/2014
1
Renilla Luciferases
IBA
01/2014
1
tyrphostin AG 1024
IBA
01/2014
Therapy/Procedure
2
Therapeutics
09/2022 - 12/2018